Trial reportTobacco control2006
Use of nicotine replacement therapy in socioeconomically deprived young smokers: a community-based pilot randomised controlled trial.
Trial report in Tobacco control, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 5 syntheses or guidelines pooled it, 50 citations in OpenAlex.
- Treatment of Nicotine Use in Adolescents Under 18 Years of Age: An Official American Thoracic Society Clinical Practice Guideline.American journal of respiratory and critical care medicine · 2025Guideline
- Nicotine replacement therapy as a smoking cessation tool for adolescents: an update.Frontiers in psychiatry · 2025Pooled it
- Nicotine replacement therapy versus control for smoking cessation.The Cochrane database of systematic reviews · 2018Pooled it
- Tobacco cessation interventions for young people.The Cochrane database of systematic reviews · 2017Pooled it
- [Guidelines for smoking cessation - update 2010].Wiener klinische Wochenschrift · 2011Guideline
- Changing low income smokers' beliefs about tobacco dependence treatment.Substance use & misuse · 2014Trial
- Helping teens quit: A systematic review and network meta-analysis of smoking cessation interventions.Public health in practice (Oxford, England) · 2026Review
- Who would be targeted by increasing the legal age of sale of cigarettes from 18 to 21? A cross-sectional study exploring the number and characteristics of smokers in England.Addiction (Abingdon, England) · 2021Article
- Psychosocial determinants of quit motivation in older smokers from deprived backgrounds: a cross-sectional survey.BMJ open · 2021Article
- Pharmacological Treatment of Youth Substance Use Disorders.Journal of child and adolescent psychopharmacology · 2019Review
- Emerging Pharmacologic Treatments for Adolescent Substance Use: Challenges and New Directions.Current addiction reports · 2016Article
- Financial incentives for smoking cessation among pregnant and newly postpartum women.Preventive medicine · 2012Review
- Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.Paediatric drugs · 2012Review
- Support for smoke-free policy, and awareness of tobacco health effects and use of smoking cessation therapy in a developing country.BMC public health · 2011Article
- Developing cessation interventions for the social and community service setting: a qualitative study of barriers to quitting among disadvantaged Australian smokers.BMC public health · 2011Article
- Trial protocol and preliminary results for a cluster randomised trial of behavioural support versus brief advice for smoking cessation in adolescents.BMC research notes · 2010Article
- Youth tobacco use cessation: 2008 update.Tobacco induced diseases · 2009Article
- Novel pharmacological approaches for treating tobacco dependence and withdrawal: current status.Drugs · 2008Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSmoking is common in young people, particularly in disadvantaged groups, and continued smoking has a major impact on quality and quantity of life. Although many young smokers want to stop smoking, little is known about the design and effectiveness of cessation services for them.
objectiveTo determine whether nicotine replacement therapy (NRT) when combined with counselling is effective in young smokers in a deprived area of Nottingham, UK. METHODS AND SUBJECTS: We surveyed smoking prevalence and attitudes to smoking and quitting in young people accessing an open access youth project in a deprived area of Nottingham, and used the information gained to design a community based smoking cessation service incorporating a randomised controlled trial of nicotine patches against placebo given in association with individual behavioural support. We resurveyed smoking prevalence among project attendees after completing the pilot study.
resultsOf 264 young people surveyed (median age 14 years, range 11-21), 49% were regular smokers. A total of 98 young people were recruited and randomised to receive either active nicotine patches on a six week reducing dose regimen (49 participants), or placebo (49 participants). Adherence to therapy was low, the median duration being one week, and 63 participants did not attend any follow up. At four weeks, five subjects receiving active NRT and two receiving placebo were abstinent, and at 13 weeks none were. Adverse effects were more common in the active group but none were serious. Smoking prevalence among 246 youth project attendees surveyed after the trial was 44%.
conclusionsThis study suggests that NRT in this context is unlikely to be effective in young smokers, not least because of low adherence to therapy. It also suggests that young smokers want help with smoking cessation, but that establishing the efficacy of smoking cessation services for young people who need them most will be very difficult.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.